Skip to main content
OpenTrials

Clinical trial condition

Anemia, Hemolytic

Explore clinical trials studying Anemia, Hemolytic. Study availability and eligibility vary by location and protocol.

1,383 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Anemia, Hemolytic trial results

Completed

Improving Scientific Rigor of Renal Clinical Endpoints for Sickle Cell Anemia

NCT04380610

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +15 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Illinois Chicage Chicago, Illinois, United States
  • St Jude Childrens Research Hospital Memphis, Tennessee, United States
  • University of Tennessee Health Science Center Memphis, Tennessee, United States
View Trial Details
Completed

Sutimlimab (BIVV009) for the Adult Participants With Cold Agglutinin Disease (CAD) Who Have Completed Phase 3 Studies (CARDINAL or CADENZA) in Japan

NCT05132127

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +5 more
Locations
  • Investigational Site Number 3920005 Ishikawa, Japan
  • Investigational Site Number 3920004 Kanagawa, Japan
  • Investigational Site Number 3920003 Osaka, Japan
  • Investigational Site Number 3920002 Saitama, Japan
View Trial Details
Completed

A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease

NCT03653247

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • UCSF Benioff Children's Hospital Oakland, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Investigational Site Number 101 Bethesda, Maryland, United States
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Oral HRS-5965 in Adult Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients Who Are Naive to Complement Inhibitor Therapy

NCT06593938

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +5 more
Locations
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • The Blood Disease Hospital of the Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Completed

A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of Crovalimab for the Management of Acute Uncomplicated Vaso-Occlusive Episodes (VOE) in Participants With Sickle Cell Disease (SCD).

NCT04912869

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations
  • Children'S Healthcare of Atlanta Atlanta, Georgia, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
  • Hospital Sao Rafael - HSR Salvador, Estado de Bahia, Brazil
  • Hospital das Clinicas - UFRGS Porto Alegre, Rio Grande do Sul, Brazil
View all 16 locations
View Trial Details

Related conditions